Table 2.
Positive G6PD deficiency newborn screening and following diagnostic results in Alberta between April 2019 and March 2022.
| Characteristic | n = 119 | % |
|---|---|---|
| Sex | ||
| Males | 106 | 89 |
| Females | 13 | 11 |
| Age at report of NBS results | 6 days (range 2–18 days) | |
| Diagnosis | ||
| Confirmed G6PD deficiency | 104 | 87 |
| False positive | 9 | 8 |
| Males | 3 | |
| Females | 6 | |
| Lost to follow up | 6 | 5 |
| Age at confirmation of diagnosis | 58 days (range 1–371 days) | |
| Follow-up with Pediatric Hematology | ||
| Edmonton clinic | 65 | 55 |
| Calgary clinic | 28 | 24 |
| Not seen in Pediatric Hematology | 26 | 22 |
| Age at consult with Pediatric Hematology | 82 days (range 19–520 days) | |
| Bilirubin screening performed | ||
| Before NBS reported | 66 | 55 |
| After NBS reported | 42 | 35 |
| Not performed | 11 | 9 |